Ex­clu­sive: Ger­man biotech de­clares Phase 2 win for non-opi­oid drug for neu­ro­path­ic pain

Al­giax Phar­ma­ceu­ti­cals’ non-opi­oid can­di­date has achieved “clin­i­cal­ly mean­ing­ful” pain re­duc­tion in a mid-stage tri­al of peo­ple with pe­riph­er­al post-sur­gi­cal neu­ro­path­ic pain, mark­ing an­oth­er suc­cess in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER